Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis
Open Access
- 24 November 2016
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 6 (4) , 46
Abstract
Epigenetic modifications leading to either transcriptional repression or activation, play an indispensable role in the development of human cancers. Epidemiological study revealed that approximately 20% of all human cancers are associated with tumor viruses. Epstein-Barr virus (EBV), the first human tumor virus, demonstrates frequent epigenetic alterations on both viral and host genomes in associated cancers—both of epithelial and lymphoid origin. The cell type-dependent different EBV latent gene expression patterns appear to be determined by the cellular epigenetic machinery and similarly viral oncoproteins recruit epigenetic regulators in order to deregulate the cellular gene expression profile resulting in several human cancers. This review elucidates the epigenetic consequences of EBV–host interactions during development of multiple EBV-induced B-cell lymphomas, which may lead to the discovery of novel therapeutic interventions against EBV-associated B-cell lymphomas by alteration of reversible patho-epigenetic markings.Keywords
Funding Information
- Wellcome Trust/DBT IA (IA/I/14/2/501537)
- National Cancer Institute (CA137894-02, CA138434-02)
This publication has 90 references indexed in Scilit:
- Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencingLeukemia, 2013
- The genetic landscape of mutations in Burkitt lymphomaNature Genetics, 2012
- EBV and human microRNAs co‐target oncogenic and apoptotic viral and human genes during latencyThe EMBO Journal, 2012
- Regulation of mammalian DNA methyltransferases: a route to new mechanismsEMBO Reports, 2011
- Epstein-Barr virus infection of human brain microvessel endothelial cells: A novel role in multiple sclerosisJournal of Neuroimmunology, 2011
- An ATM/Chk2-Mediated DNA Damage-Responsive Signaling Pathway Suppresses Epstein-Barr Virus Transformation of Primary Human B CellsCell Host & Microbe, 2010
- Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growthProceedings of the National Academy of Sciences, 2009
- Epstein‐Barr virus and the pathogenesis of Burkitt's lymphoma: More questions than answersInternational Journal of Cancer, 2009
- Epstein–Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4Proceedings of the National Academy of Sciences, 2006
- Epstein–Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cellsProceedings of the National Academy of Sciences, 2006